Teleflex (NYSE:TFX) may be getting out of the orthopedic OEM business, but it’s still going strong with its other OEM businesses, as evidenced by a newly expanded facility in Jaffrey, N.H., the medical device company opened last week.
Intuitive Surgical
Medical Device Companies: Medtech’s best/worst valued stocks
One way to assess stock values is to compare the stock’s share price with its asset value.
The latter is the number of shares outstanding divided into total assets. When the result is compared with share prices, it can help investors decide whether a stock is over- or under-valued.
We took a look at the asset values for 15 of the world’s largest pure-play medical device companies and then compared them with the companies’ stock price.
Battle in Silicon Valley: Device makers trade barbs in the fight to gain share in robot assisted procedures
Hospitals: Cap-ex market still constrained | Wall Street Beat
Mako Surgical (NSDQ:MAKO) Rio robotic surgery system needs to move from ‘nice to have’ to ‘need to have’ if it’s going to gain traction with hospitals.
That’s because the capital expenditure market is still under pressure from the weak economy, according to Leerink Swann analyst Richard Newitter, citing the un-named hospital CFO.
Study: Robot assisted prostate surgery may lower rates of incontinence, impotence
Robot assisted prostate surgery may lower rates of urinary incontinence and post-surgery impotence when compared with minimally invasive laparoscopy, according to a small Italian study.
The study only comprised 120 patients who were randomized to receive a prostatectomy with either an unnamed robot assistant or with tiny tools manipulated by hand. All surgeries were performed by a single surgeon.
Intuitive Surgical lawsuit: Product liability cases won’t be combined
The plaintiffs in a quartet of lawsuits filed against Intuitive Surgical (NSDQ:ISRG) will not be able consolidate the cases under a single judge in either Louisiana or California.
MassDevice.com +3 | The top 3 med-tech stories for July 24, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Prostate cancer: Intuitive Surgical CEO Guthart on testing and “watchful waiting”
Intuitive Surgical (NSDQ:ISRG) president & CEO Gary Guthart doesn’t believe in taking a passive approach to men’s health.
Derivatives lawsuit stayed against Intuitive Surgical
Intuitive Surgical (NSDQ:ISRG) and some of its shareholders agreed to stay a lawsuit filed against the medical device company over allegedly misleading statements made during the height of the economic downturn in 2008 and 2009.
Med-tech trends to watch in the post-healthcare reform era | MassDevice.com On Call
MASSDEVICE ON CALL — Healthcare reporting service Becker’s Spine Review noted 9 areas of innovation to watch in the post-Affordable Care Act age, chief among them the move from internal medical device development at big companies to entrepreneurial manufacturing.
Also on the list of hotspots was a surge in European regulatory wins for new medical devices, an expanding market in China and more device makers looking at Brazil as an attractive market.
MassDevice.com +7 | The top 7 med-tech stories for the week of July 16, 2012
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.